The Challenge for Fine and Specialty Chemical Firms
11:17 AM MDT | March 19, 2009 | By GIRISH MALHOTRA
The global chemical industry is going through multiple transformations and the current economic environment is not helping either. The sector needs to address the following.
How to react to the current slow down?
What are their long-term prospects?
Companies in Europe and
Some of the old giants have disappeared. Recent re-factoring of the European companies to rationalize their businesses has caused more turmoil than solutions as the companies are still losing money. Some are trying to find themselves and some have given themselves new names after reorganizing. Some of the new entities have not found equilibrium.
The lack of growth (i.e. growth equal to GDP growth is no growth) has been a challenge - some segments have had higher than GDP growth but many are lower. On the other hand, it has been an exhilarating time for those companies that have been growing faster than planned.
As the world grapples with the current slow down-more so in the developed countries than the developing countries-the future looks murky. To conserve profits companies have selectively shuttered their plants. This might be prudent for the short-term but mothballing plants might not solve the long-term ills.
The impact of the expiration of the pharmaceutical patents and lack of new drugs in the pipeline will reposition the global fine chemical industry. We will begin to see a sea change in the second half of 2010.
What is the recourse for the future?
Current markets for the chemical products can be categorized as follows.
Slow or no growth (growth equal to or less than GDP)
Growth (growth greater than GDP)
In the current economic down turn, the human and social impact of shutting down and/or moving R&D and manufacturing from the slow and/no growth countries to the growth countries can have significant negative connotations. However, such moves might be necessary for the multinational companies. In the slowing global economy, due to political sensitivity, moving from developed countries and investing in growth markets is a going to take longer than normal. Lack of rapid decision-making might further complicate strategy development.
Until a few years ago, growth in developing countries was slow and these markets could be supplied from developed countries. However, with much higher growth in these developing countries, it has become necessary for the multinationals to fulfill the market needs either by opening R&D and manufacturing sites or collaborating with local partners.
Multinationals face another challenge in developing countries. It comes from the local enterprises that have served the local and global markets. These enterprises might not be technologically strong but it is a matter of time before they could become fierce competitors.
More than 50% of the global population lives outside developed countries. In the next few years growth is going to come from these markets. They might not require the technologies currently used in the developed countries. Technologies to suit the local market preferences and environment might have to be developed. A joint collaboration between the local companies and multinationals can be a fast track option. Going it alone also could be an option. However, it would require understanding of local markets. In addition, multinational companies will have to invest in technologies and capacities that are economic and can meet the market needs from fewer plants. This could be a challenge but is necessary for their survival.
The manufacture of commodity (slow or no growth) products will move to the lowest wage countries.
The newest technology (growth better than GDP) products will be developed in the labs in the developed countries and could be manufactured anywhere to serve their respective needs.
The world is changing faster than we can strategize and implement.
Connect with IHS Chemical Week
Our related sites